Release Notes: Version 20210305
About this release
This release (version 20210305) provides the latest updates to the Canadian Clinical Drug Data Set in English and French. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
NTP
There are 4 new deprecated NTP concepts with this release. In the first concept, the CCDD dose form map was modified to reflect the dose form in DPD. For the second and third concepts, the dose form for all corresponding products was changed in DPD. For the fourth concept, the vial size for the corresponding product was changed in DPD.
ntp_code | Former ntp_formal_name | Former ntp_fr_description | Type of change | Replaced with ntp_code | Replaced with ntp_formal_name | Replaced with ntp_fr_description |
|---|---|---|---|---|---|---|
9002743 | bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for solution for injection | bacille de Calmette-Guérin sous-souche TICE 800000000 unité par fiole poudre pour solution injectable | Deprec | 9014445 | bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution | bacille de Calmette-Guérin sous-souche TICE 800000000 unité par fiole poudre pour solution intravésicale |
9001076 | ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 1000 mg prolonged-release oral tablet | ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 1000 mg comprimé oral à libération prolongée | Deprec | 9014452 | ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 1000 mg modified-release oral tablet | ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 1000 mg comprimé oral à libération modifiée |
9001049 | ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg prolonged-release oral tablet | ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 500 mg comprimé oral à libération prolongée | Deprec | 9014453 | ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg modified-release oral tablet | ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 500 mg comprimé oral à libération modifiée |
9014414 | tozinameran 30 mcg per 0.3 mL suspension for injection 1.5 mL vial | tozinaméran 30 mcg par 0,3 mL suspension injectable 1,5 mL fiole | Deprec | 9014467 | tozinameran 30 mcg per 0.3 mL suspension for injection 1.8 mL vial | tozinaméran 30 mcg par 0,3 mL suspension injectable 1,8 mL fiole |
MP
Five MP formal name changes have occurred resulting from the deprecated NTPs.
mp_code March 2021 Release | mp_formal_name March 2021 Release | mp_fr_description March 2021 Release | mp_formal_name February 2021 Release | mp_fr_description February 2021 Release |
|---|---|---|---|---|
| 02153513 | ONCOTICE (bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution) MERCK CANADA INC | ONCOTICE (bacille de Calmette-Guérin sous-souche TICE 800000000 unité par fiole poudre pour solution intravésicale) MERCK CANADA INC | ONCOTICE (bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for solution for injection) MERCK CANADA INC | ONCOTICE (bacille de Calmette-Guérin sous-souche TICE 800000000 unité par fiole poudre pour solution injectable) MERCK CANADA INC |
| 02251787 | CIPRO XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 1000 mg modified-release oral tablet) BAYER INC | CIPRO XL (ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 1000 mg comprimé oral à libération modifiée) BAYER INC | CIPRO XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 1000 mg prolonged-release oral tablet) BAYER INC | CIPRO XL (ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 1000 mg comprimé oral à libération prolongée) BAYER INC |
| 02247916 | CIPRO XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg modified-release oral tablet) BAYER INC | CIPRO XL (ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 500 mg comprimé oral à libération modifiée) BAYER INC | CIPRO XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg prolonged-release oral tablet) BAYER INC | CIPRO XL (ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 500 mg comprimé oral à libération prolongée) BAYER INC |
| 02416433 | PMS-CIPROFLOXACIN XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg modified-release oral tablet) PHARMASCIENCE INC | PMS-CIPROFLOXACIN XL (ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 500 mg comprimé oral à libération modifiée) PHARMASCIENCE INC | PMS-CIPROFLOXACIN XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg prolonged-release oral tablet) PHARMASCIENCE INC | PMS-CIPROFLOXACIN XL (ciprofloxacine (ciprofloxacine, chlorhydrate de ciprofloxacine) 500 mg comprimé oral à libération prolongée) PHARMASCIENCE INC |
| 02509210 | PFIZER-BIONTECH COVID-19 VACCINE (tozinameran 30 mcg per 0.3 mL suspension for injection 1.8 mL vial) BIONTECH MANUFACTURING GMBH | PFIZER-BIONTECH COVID-19 VACCINE (tozinaméran 30 mcg par 0,3 mL suspension injectable 1,8 mL fiole) BIONTECH MANUFACTURING GMBH | PFIZER-BIONTECH COVID-19 VACCINE (tozinameran 30 mcg per 0.3 mL suspension for injection 1.5 mL vial) BIONTECH MANUFACTURING GMBH | PFIZER-BIONTECH COVID-19 VACCINE (tozinaméran 30 mcg par 0,3 mL suspension injectable 1,5 mL fiole) BIONTECH MANUFACTURING GMBH |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]